Russell Clark Investment Management’s Quest Diagnostics DGX Stock Holding History

Russell Clark Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,000	Closed	-$1.08M	–	43
2018 Q3	$1.08M	Hold	10,000	–	–	0.25%	61
2018 Q2	$1.1M	Hold	10,000	–	–	0.22%	61
2018 Q1	$1M	Hold	10,000	–	–	0.2%	68
2017 Q4	$985K	Hold	10,000	–	–	0.21%	60
2017 Q3	$936K	Hold	10,000	–	–	0.21%	57
2017 Q2	$1.11M	Buy	+10,000	New	+$1.06M	0.31%	45

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Russell Clark Investment Management's DGX Position: Q4 2018 in Review

Russell Clark Investment Management sold out of Quest Diagnostics (DGX) in Q4 2018, closing a stake of 10,000 shares — an estimated $1.08M sold.

Russell Clark Investment Management first reported a position in DGX in Q2 2017 and held it in 6 quarters. The position peaked at $1.11M in Q2 2017. 625 funds tracked by Wall St. Rank hold DGX as of Q4 2018.

Russell Clark Investment Management reported no remaining Quest Diagnostics position as of Q4 2018 after selling out during the quarter.
Russell Clark Investment Management sold 10,000 Quest Diagnostics shares in Q4 2018, an estimated $1.08M.
Russell Clark Investment Management first reported a position in Quest Diagnostics in Q2 2017 and held it in 6 quarters.
Russell Clark Investment Management's Quest Diagnostics position peaked at $1.11M in Q2 2017.
625 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2018.

Based on Russell Clark Investment Management's 13F filing for Q4 2018, filed 31 Jan 2019.